SCHEMBL26259196

SCHEMBL26259196

CC(C)(C)CCC(C)(C)C(=O)NCC(C)(C)COCC(C)(C)CNC(=O)CC(C)(C)COP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24340622 0.86 TDP1 (0.31)
SCHEMBL24340597 0.81
SCHEMBL24340877 0.77
SCHEMBL26034793 0.77
SCHEMBL27383486 0.76 MEN1 (0.31)
SCHEMBL26035966 0.74
SCHEMBL24340876 0.74
SCHEMBL24340596 0.73
SCHEMBL26037644 0.72
SCHEMBL25844866 0.71 ESR1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265430-A1 RNAi Agents for Inhibiting Expression of DUX4, Compositions Thereof, And Methods of Use SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT 2023-08-24 US disclosed